Crawley, UK, July 13, 2009
Elekta, Europe’s leading manufacturer of radiotherapy equipment
and oncology software, has hosted its first European Radiation
Oncology Information Systems Advisory Board meeting.
Comprised of oncologists, physicists and IT professionals from
Europe, the newly-formed Board will work closely with Elekta to
identify, develop and refine software solutions that deliver
better overall communication, process efficiency and quality,
human care.
“Elekta is proud to launch our first Radiation Oncology
Information Systems Advisory Board for European users,” says
Nicky Wilson, International Business Development Director for
Oncology Information Systems. “With an increasing demand for
Elekta products globally, our customers are keen to get
involved, as well as excited to help shape the future of
Elekta’s software system, MOSAIQ®.”
With the advancement of technology, increasing regulatory
requirements and the need to reduce costs and increase
efficiency within oncology practices, oncology-specific
information systems are beginning to play a greater role within
clinical departments. As Elekta’s growth in the OIS market has
increased rapidly, consistent European demand and interest
facilitated the launch of this new Advisory Board.
"Streamlining information, image and treatment workflows is
today the most important factor for treatment quality, patient
safety and efficient patient care,” says Frank Lohr, M.D., vice
chairman, Department of Radiation Oncology at University of
Mannheim, Mannheim, Germany. “MOSAIQ enables us to manage and
provide optimal treatment for the increasing number of our
patients. Our feedback within the Elekta Radiation Oncology
Information Systems Advisory Board will help to continue the
improvement in cancer therapy based on ever advancing software
tools."
For the latest software developments from Elekta, visit
elekta.com/impac.
Media Inquiries:
Laura Francis, International Business Marketing Manager, OIS
solutions,
laura.francis@elekta.com
Nicky Wilson, International Business Development Director, OIS
solutions,
nicky.wilson@elekta.com
About Elekta
Elekta
is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The
company develops sophisticated state of the art tools and
treatment planning systems for radiation therapy and
radiosurgery, as well as workflow enhancing software systems
across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer
confidence to both healthcare providers and patients, Elekta
aims to improve, prolong and even save patient lives, making the
future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in
over 5,000 hospitals globally, and every day more than 100,000
patients receive diagnosis, treatment or follow-up with the help
of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate
headquarter is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. For more
information about Elekta, please visit
www.elekta.com. |
|
Media Inquiries:
Michelle Lee
PR and Advertising Manager
Tel: +1 770-670-2447
michelle.lee@elekta.com
Global Marketing inquiries:
Peter Ejemyr
Group VP,
Corporate Communications, Tel: +46 733 611 000
peter.ejemyr@elekta.com
Investor inquiries:
Lena Schattauer,
Investor Relations,
Elekta AB
Tel: +46 8 587 257 22, +46 70 595 51 00,
lena.schattauer@elekta.com
Link Disclaimer
|
